Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial

T Ruzicka; C. W Lynde; G. B. E Jemec; T Diepgen; J Berth-Jones; P. J Coenraads; A Kaszuba; R Bissonnette; Elina Varjonen; P Hollo; F Cambazard; M Lahfa; P Elsner; F Nyberg; A Svensson; T. C Brown; M Harsch; J Maares

Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial

T Ruzicka, C. W Lynde, G. B. E Jemec, T Diepgen, J Berth-Jones, P. J Coenraads, A Kaszuba, R Bissonnette, Elina Varjonen, P Hollo, F Cambazard, M Lahfa, P Elsner, F Nyberg, A Svensson, T. C Brown, M Harsch, J Maares

Department of Dermatology, Allergology and Venereology

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	British Journal of Dermatology
Volume	158
Issue number	4
Pages (from-to)	808-817
Number of pages	10
ISSN	0007-0963
Publication status	Published - 2008
MoE publication type	A1 Journal article-refereed

Cite this

Ruzicka, T., Lynde, C. W., Jemec, G. B. E., Diepgen, T., Berth-Jones, J., Coenraads, P. J., Kaszuba, A., Bissonnette, R., Varjonen, E., Hollo, P., Cambazard, F., Lahfa, M., Elsner, P., Nyberg, F., Svensson, A., Brown, T. C., Harsch, M., & Maares, J. (2008). Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. British Journal of Dermatology, 158(4), 808-817.

@article{954b0a114f874a0d819eb4d01812d34e,

title = "Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial",

author = "T Ruzicka and Lynde, {C. W} and Jemec, {G. B. E} and T Diepgen and J Berth-Jones and Coenraads, {P. J} and A Kaszuba and R Bissonnette and Elina Varjonen and P Hollo and F Cambazard and M Lahfa and P Elsner and F Nyberg and A Svensson and Brown, {T. C} and M Harsch and J Maares",

year = "2008",

language = "English",

volume = "158",

pages = "808--817",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "4",

}

Ruzicka, T, Lynde, CW, Jemec, GBE, Diepgen, T, Berth-Jones, J, Coenraads, PJ, Kaszuba, A, Bissonnette, R, Varjonen, E, Hollo, P, Cambazard, F, Lahfa, M, Elsner, P, Nyberg, F, Svensson, A, Brown, TC, Harsch, M & Maares, J 2008, 'Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial', British Journal of Dermatology, vol. 158, no. 4, pp. 808-817.

Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids : results of a randomized, double-blind, placebo-controlled, multicentre trial. / Ruzicka, T; Lynde, C. W; Jemec, G. B. E et al.

In: British Journal of Dermatology, Vol. 158, No. 4, 2008, p. 808-817.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids

T2 - results of a randomized, double-blind, placebo-controlled, multicentre trial

AU - Ruzicka, T

AU - Lynde, C. W

AU - Jemec, G. B. E

AU - Diepgen, T

AU - Berth-Jones, J

AU - Coenraads, P. J

AU - Kaszuba, A

AU - Bissonnette, R

AU - Varjonen, Elina

AU - Hollo, P

AU - Cambazard, F

AU - Lahfa, M

AU - Elsner, P

AU - Nyberg, F

AU - Svensson, A

AU - Brown, T. C

AU - Harsch, M

AU - Maares, J

PY - 2008

Y1 - 2008

M3 - Article

VL - 158

SP - 808

EP - 817

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 4

ER -